Immuneering Corporation (IMRX) scores 46 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is $0.00. Quantitative score: 50/100. Qualitative score: 60/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.